The combination of STAT3 knockdown and gemcitabine can restore sensitivity to gemcitabine in pancreatic cancer cell line by inducing proapoptotic signals and increasing the cell population in G1 cell cycle arrest [43]. This evidence concerns the gene STAT3 and familial pancreatic carcinoma.